These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23301925)

  • 21. Impact of lifestyle-related disease on conversion and reversion in patients with mild cognitive impairment: after 12 months of follow-up.
    Osone A; Arai R; Hakamada R; Shimoda K
    Int J Geriatr Psychiatry; 2016 Jul; 31(7):740-8. PubMed ID: 26593034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.
    Monsell SE; Liu D; Weintraub S; Kukull WA
    Int Psychogeriatr; 2012 Oct; 24(10):1553-60. PubMed ID: 22717299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study.
    Razay G; Williams J; King E; Smith AD; Wilcock G
    Dement Geriatr Cogn Disord; 2009; 28(1):70-4. PubMed ID: 19648748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.
    Dickerson BC; Sperling RA; Hyman BT; Albert MS; Blacker D
    Arch Gen Psychiatry; 2007 Dec; 64(12):1443-50. PubMed ID: 18056553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
    Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
    Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular hypertrophy and blood pressure as predictors of cognitive decline in old age.
    Kähönen-Väre M; Brunni-Hakala S; Lindroos M; Pitkala K; Strandberg T; Tilvis R
    Aging Clin Exp Res; 2004 Apr; 16(2):147-52. PubMed ID: 15195990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between hypertension and cognitive function: A cross-sectional study in people over 45 years old in China.
    Wei J; Yin X; Liu Q; Tan L; Jia C
    J Clin Hypertens (Greenwich); 2018 Nov; 20(11):1575-1583. PubMed ID: 30259624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
    Han JY; Besser LM; Xiong C; Kukull WA; Morris JC
    Alzheimer Dis Assoc Disord; 2019; 33(2):87-94. PubMed ID: 30633043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates.
    Duara R; Loewenstein DA; Greig MT; Potter E; Barker W; Raj A; Schinka J; Borenstein A; Schoenberg M; Wu Y; Banko J; Potter H
    Am J Geriatr Psychiatry; 2011 Nov; 19(11):951-60. PubMed ID: 21422909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orthostatic hypotension and symptomatic subclinical orthostatic hypotension increase risk of cognitive impairment: an integrated evidence review and analysis of a large older adult hypertensive cohort.
    Peters R; Anstey KJ; Booth A; Beckett N; Warwick J; Antikainen R; Rockwood K; Peters J; Bulpitt CJ
    Eur Heart J; 2018 Sep; 39(33):3135-3143. PubMed ID: 30052878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of mild cognitive impairment is higher in hypertensive population: a cross-sectional study in less developed northwest China.
    Heizhati M; Wang L; Li N; Li M; Pan F; Yang Z; Wang Z; Abudereyimu R
    Medicine (Baltimore); 2020 May; 99(19):e19891. PubMed ID: 32384432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effects of Mean of Visit-to-Visit Blood Pressure on Incident Brain Vascular Lesions and Functional-Cognitive Decline.
    Gyanwali B; Cai CXT; Chen C; Vrooman H; Tan CS; Hilal S
    J Alzheimers Dis; 2021; 82(2):561-573. PubMed ID: 34057087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is Baseline Orthostatic Hypotension Associated With a Decline in Global Cognitive Performance at 4-Year Follow-Up? Data From TILDA (The Irish Longitudinal Study on Ageing).
    McNicholas T; Tobin K; Carey D; O'Callaghan S; Kenny RA
    J Am Heart Assoc; 2018 Oct; 7(19):e008976. PubMed ID: 30371298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging.
    Waldstein SR; Giggey PP; Thayer JF; Zonderman AB
    Hypertension; 2005 Mar; 45(3):374-9. PubMed ID: 15699446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
    Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
    Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
    Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
    Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.
    Thomas KR; Edmonds EC; Eppig J; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2018; 64(1):195-204. PubMed ID: 29865077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.